Davis Polk & Wardwell advised Ultra Clean Holdings, Inc. on the transaction. Ultra Clean Holdings, Inc. (UCT) announced its acquisition of HIS Innovations Group. UCT paid $50...
UCT’s Acquisition of HIS Innovations Group
IDEAYA Biosciences’ $143.8 Million Common Stock Offering
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the several underwriters. IDEAYA Biosciences, Inc. (NASDAQ:IDYA)...
Aligos Therapeutics’ $92 Million Private Placement
Davis Polk & Wardwell advised Piper Sandler, acted sole placement agent, on the private placement. Aligos Therapeutics, Inc. announced its private placement $92 million private placement of...
Marvell Technology’s $1 Billion Notes Offering
Weil, Gotshal & Manges advised Marvell Technology, Inc., and Davis Polk & Wardwell advised the representatives of the underwriters on the offering. Marvell Technology, Inc. (Nasdaq:MRVL)...
Intuit’s $4 Billion Notes Offering
Gibson, Dunn & Crutcher advised Intuit Inc., and Davis Polk & Wardwell advised the representatives of the underwriters in the offering. Intuit Inc. (Nasdaq:INTU) announced its $750...
Vishay Intertechnology’s $750 Million Convertible Senior Notes Offering
Davis Polk & Wardwell advised the representative of the initial purchasers on the offering. Vishay Intertechnology, Inc. (NYSE: VSH) announced it has completed its offering of $750 million aggregate...
CSG Systems International’s $425 Million Convertible Senior Notes Offering
Simpson Thacher & Bartlett advised CSG Systems International, Inc., and Davis Polk & Wardwell advised the representatives of the initial purchasers on the offering. CSG Systems...
Natera’s $250 Million Follow-On Offering
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Natera, and Davis Polk & Wardwell advised the representatives of the several underwriters on the offering. Natera, Inc....
Recursion Pharmaceuticals’ $300 Million At-The-Market Offering
Wilson Sonsini Goodrich & Rosati advised Recursion Pharmaceuticals, Inc.; and Davis Polk & Wardwell LLP advised Jefferies LLC, as sales agent, in the offering. Recursion Pharmaceuticals,...
Upgrade’s $100 Million Acquisition of Uplift
Davis Polk & Wardwell advised Upgrade, Inc. on the transaction. Upgrade, Inc. announced the acquisition of Uplift, Inc., the leading provider of Buy Now Pay Later (BNPL)...
IDEAYA Biosciences’ $250 Million At-the-Market Offering
Latham & Watkins LLP advised IDEAYA Biosciences, Inc., while Davis Polk & Wardwell LLP advised Jefferies LLC in the offering. IDEAYA Biosciences, Inc. announced the SEC-registered at-the-market...
Coherus BioSciences’ $57.5 Million Follow-On Offering
Latham & Watkins advised Coherus BioSciences, and Davis Polk advised J.P. Morgan Securities LLC and Citigroup Global Markets Inc. on the offering. Coherus BioSciences, Inc. (“Coherus”, Nasdaq:...